0.74 USD
+0.01 (+0.82%)
0.7548 USD
+0.01 (+2%)
ChartMill assigns a Buy % Consensus number of 82% to KAPA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.5. This target is 1048.64% above the current price.
KAPA was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about KAPA.
In the previous month the buy percentage consensus was at a similar level.
KAPA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-20 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-07 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-03 | HC Wainwright & Co. | Initiate | Buy |
| 2025-03-31 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-27 | Maxim Group | Initiate | Buy |
| 2025-03-20 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-22 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-10-14 | EF Hutton | Initiate | Buy |
KAIROS PHARMA LTD / KAPA FAQ
What is the average price target for KAIROS PHARMA LTD (KAPA) stock?
9 analysts have analysed KAPA and the average price target is 8.5 USD. This implies a price increase of 1048.64% is expected in the next year compared to the current price of 0.74.
Can you provide the consensus rating for KAIROS PHARMA LTD stock?
The consensus rating for KAIROS PHARMA LTD (KAPA) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.